Table 1.
Variables | N | CTC/7.5 mL | p-Value | |
---|---|---|---|---|
Mean | Range | |||
CTC count at base | 60 | 8 | 0–184 | 0.042 |
PSA (ng/mL) | ||||
<30 | 30 | 2 | 0–3 | 0.021 |
≥30 | 30 | 15 | 0–184 | |
Biopsy Gleason score | ||||
7–8 | 29 | 2 | 0–6 | 0.003 |
9–10 | 31 | 19 | 0–184 | |
EOD | ||||
1–2 | 39 | 1 | 0–14 | 0.034 |
3–4 | 21 | 23 | 0–184 | |
Hemoglobin (g/dL) | ||||
<11.5 | 35 | 18 | 0–184 | 0.059 |
≥11.5 | 25 | 5 | 0–13 | |
Serum albumin (g/dL) | ||||
<3.7 | 28 | 19 | 0–184 | 0.059 |
≥3.7 | 22 | 4 | 0–12 | |
Alkaline phosphatase (IU/L) | ||||
<313 | 21 | 3 | 0–34 | 0.002 |
≥313 | 39 | 18 | 0–184 | |
Lactate dehydrogenase (IU/L) | ||||
<226 | 26 | 2 | 0–18 | 0.066 |
≥226 | 34 | 19 | 0–184 | |
Disease involvement | ||||
Only bone | 42 | 6 | 0–45 | 0.014 |
Bone plus node | 18 | 15 | 0–184 |
CTC median and range are expressed as cells per 7.5 mL of blood. The extent of bone metastasis was classified by the extent of disease (EOD) grade.